Sutro Biopharma Announces $85.0 Million Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil gains after Trump says US will hit Iran 'very hard tonight'
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
Sutro Biopharma (STRO) IPO Opens Modestly Higher
September 27, 2018 12:36 PM EDTToday's IPO for Sutro Biopharma, Inc. (NASDAQ: STRO) opened for trading at $15.12 after pricing 5,667,000 shares of its common stock at a price to the public of $15.00 per share.
In addition, the underwriters have been granted a 30-day option to purchase up to an... More
